Drug profile · INN
helium
HELIUM, USP
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
helium (HELIUM, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 11857697
Compositions and methods for obtaining 3-dimensional lung-like epithelium and related uses thereof
granted -
US 11441184
Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)
granted -
US 11261237
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
granted -
US 10480031
Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem Cells (IPSCs)
granted -
US 10081668
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
granted -
US 9649340
Methods for producing enriched populations of human retinal pigment epithelium cells
granted -
US 9339528
Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist
granted -
US 8609408
Method for the reconstruction of a tissue-engineered human corneal endothelium
granted
Frequently asked questions
What is helium?
helium (HELIUM, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for helium?
HELIUM, USP is a marketed brand name for helium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of helium?
helium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.